Gianmaria Baldin

21PUBLICATIONS
41CO-AUTHORS
Respiratory diseasesPharmacogenomicsInnate immunityRegenerative medicine (incl. stem cells)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 21, 2026
Risk of Virological Failure After Switch to a Tenofovir-Sparing Dual Therapy in Virologically Suppressed People With HIV and Past HBV Infection.

|May 15, 2026
'Leaving no stones unturned': up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort.

|May 07, 2026
Dengue-specific T-cell memory following natural infection: a comparative analysis between people living with HIV and HIV-negative individuals.

|Sep 27, 2025
Real-World Experience with Long-Acting Injectable Cabotegravir/Rilpivirine in HIV Patients with Unsuppressed Viral Load.

Marcello Trizzino, Luca Pipitò, Pierluigi Francesco Salvo

|Oct 31, 2024
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.

Arturo Ciccullo, Gianmaria Baldin, Adriana Cervo

|Oct 29, 2024
Cardiovascular Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Virologically Suppressed PLWHIV: A Comparative Analysis of CVD Scores.

Arturo Ciccullo, Valentina Iannone, Damiano Farinacci

Pageof 4

Frequent Collaborators

13 joint publications

Arturo Ciccullo

6 joint publications

Gaetana Sterrantino

6 joint publications

Alberto Borghetti

4 joint publications

Andrea Giacomelli